Shin Fomushima Nuclear Accident Ya Karu Cutar Thyroid Cancer?

A cikin watan Maris na 2011, wani hatsari a Fukushima Daiichi Nuclear Power Plant a Fukushima, Japan-wanda aka haifar da wani girgizar kasa tsunami tsunami da ya haifar da shuka-ya haifar da saki radiation da kuma nunawa ga kayan rediyo a Japan da kuma a yankunan da ke ƙasa makaman nukiliya.

Rikicin nukiliya na hatsari irin su daya a Fukushima da haɗarin Chernobyl na shekarar 1986 ya haifar da sakin iodine-131.

Bayyanawa ga iodine rediyo-131 shine sanadin haɗari ga ciwon daji na thyroid , kuma hadarin ya fi girma idan hadarin ya faru a jarirai, yara, da matasa. Shin akwai damuwar damuwa, kuma idan haka, me za a iya yi?

Binciken

An gani babban karu a jariri zuwa yarinya na ciwon maganin thyroid wanda ya fara kusan shekaru biyar bayan hadarin Chernobyl . Abinda ya faru shine mafi girma a wurare irin su Belarus, wanda yake a hanyar hanyar kare makaman nukiliya na Chernobyl, amma magungunan potassium mai yaduwar cutar potassium ba su kare shi ba. (Wasu yankunan Chernobyl, irin su Poland, sun samo allunan potassium na iodide , wanda ke kare maganin ka daga karfin maida maida rediyo idan an dauki shi a cikin sa'o'i kafin da bayan watsawa.)

Da aka ba da kwarewar Chernobyl da kuma yaduwar jama'a a Japan, an kaddamar da binciken Gudanar da Lafiya ta Fukushima a watan Yulin 2011 don kimanta hadarin kamuwa da radiation a kan yawan jama'a.

A binciken ya shafi manyan-sikelin thyroid duban dan tayi nunawa na yawan kewaye da Fukushima a cikin wani ƙoƙari na gano m thyroid ciwon daji.

Masu bincike na kasar Japan suna ƙoƙari su tabbatar da cewa akwai alamar tabbatar da dangantaka ta hanyar rikici ta Fukushima da kuma kara yawan ƙara yawan ciwon daji na thyroid a Fukushima.

Sakamakon farko sun kasance game da masu bincike, wadanda suka gano rabin rahotannin da aka bincikar su suna da thyroid nodules wanda zai iya zama a halin yanzu halin da ake ciki ko kuma ya zama mai wahala a nan gaba. Ɗaya daga cikin binciken binciken da aka yi a cikin shekara ta 2015 cewa rahoton cutar ciwon thyroid a yara Fukushima ya fi kusan miliyan 600 da miliyan, lokacin da ake sa ran zai kasance 1 zuwa 3 lokuta da miliyan yara.

A cewar masu bincike, duk da haka, yayin da akwai ciwon daji na ciwon maganin ciwon thyroid, hakan ya fi ƙanƙan da yawan karuwar da ya faru bayan Chernobyl. Wannan ya haifar da masu bincike don cimma burin cewa "yankunan da ke cikin Fukushima mazauna sun fi muni daga wadanda suka mutu daga hadarin Chernobyl, kuma babu wata hujja mai karfi da ke goyon bayan maganganu na ciwon maganin ciwon maganin ciwon maganin ciwon maganin ciwon dajin da ke cikin Fukushima."

Ƙarin Cancer Cancer, ko Gano mafi kyau a Fukushima?

Wasu masu bincike na kasar Japan sun nuna cewa ci gaba da yin amfani da tayi a cikin Fukushima yana iya gano ƙananan thyroid nodules-wanda ake kira microcarcinomas-kuma cewa kimanin ƙididdigar rigakafin da ake yi na thyroid nodules ya fito ne daga nesa sosai.

Suna jayayya cewa mafi yawan nodules-kuma ƙarshe, ƙarin ciwon daji na thyroid-za a iya ganewa a cikin waɗanda aka nuna a matsayin yara zuwa ga Fukushima fallout.

Amma suna fadada cewa karuwa a ciwon daji na thyroid shine ainihin sakamakon sakamakon yaduwa da yawa da ke faruwa a Fukushima, tare da kara yawan kwayar cutar thyroid wanda ya haifar da hadarin nukiliya. Suna bayar da shawarar cewa za a sami ciwon ciwon maganin thyroid saboda masu bincike da mazaunin Fukushima suna neman shi, da kuma yin amfani da kayan aiki masu mahimmanci don gano shi.

Wannan fitowar ta nuna misalin irin wannan gwagwarmaya da ke faruwa a Amurka, inda ake karuwar yawan ciwon daji na thyroid don ƙarin kayan bincike masu ganewa wanda ke iya gano microcarcinomas, kuma ba ainihin ƙaruwar cutar ciwon thyroid ba.

Game da binciken Fukushima, Peter Kopp, MD, editan jaridar Thyroid da Farfesa na Medicine, Division of Endocrinology, Metabolism, da Medicine Mills, a Jami'ar Chicago's Northwestern University, ya ce:

Nazarin binciken da ya shafi makaman nukiliya a Chernobyl da Fukushima akan batun kiwon lafiya da zamantakewar al'umma ya ci gaba da zama mai ban sha'awa. A wannan batu, babu wata hujja bayyananne cewa hadarin Fukushima ya haifar da ƙarin haɓari na carcinomas thyroid, wani binciken da ya bambanta tare da lura bayan hadarin Chernobyl. Halin da ake ciki na rashin lafiyar thyroidancies wanda aka gano ta hanyar binciken da yawan mutanen Fukushima ke nuna alamun kalubalen da ke tattare da shirye-shiryen bidiyo.

Duk da haka, duk wani tabbaci na ƙarshe ba zai kasance ba, kuma ci gaba da lura da yawan mutanen Fukushima, da kuma cikakkiyar fasalin irin kwayoyin halitta da kuma gyaran gyare-gyare a cikin wadanda ake gano thyroid carcinomas, sun kasance masu muhimmanci.

Kalma Daga

Duk da yake masu bincike na kasar Japan ba su kafa wani karuwar yawan ciwon daji na thyroid ba wanda zai iya kai tsaye ga hadarin nukiliya na Fukushima, suna nuna cewa ana bukatar karin bincike don gano yanayin.

A ƙarshe, ci gaba da nazarin annoba za su taimaka wajen tantance ko yaduwa ga maida rediyo-131 bayan Fukushima yana da matakin isa ya haifar da karuwa mai girma a ciwon daji na thyroid-irin wanda ya faru bayan Chernobyl-ko kuma idan karuwa ne kawai ta hanyar aiki na ƙwarewar, yaduwa, da kuma maganin ciwon daji na thyroid.

> Sources:

> Hukumar Ƙasa ta Duniya akan Taimakon Rediyo 2009 Aiwatar da shawarwarin Hukumar don Kare Mutane a Yanayin Harkokin Kiran gaggawa. Publication na ICRP 109. Ann. ICRP 39. 2009.

> Majalisar Dokokin Kimiyya ta Majalisar Dinkin Duniya kan tasirin Atomic Radiation. "Sources da kuma tasirin radiation radiation." UNSCEAR 2008 Report zuwa ga Majalisar Duka tare da ƙarin kimiyya. Volume II, Shafin Farko D: Rawanin lafiyar saboda radiation daga hadarin Chernobyl. Majalisar Dinkin Duniya, New York, NY. 2011.

> Yamashita S, Thomas G (eds). Ciwon Cutar Doroid da Magungunan Nuclear: Rawanin Cutar Chernobyl da Fukushima. Cibiyar Nazari, Elsevier, Inc., Cambridge, MA. 2017.

> Yamashita, S et. al. "Koyaswa daga Fukushima: Binciken Bincike na Cancer Cancer Bayan Fukushima Nuclear Power Plant Accident." Thyroid. Volume 28, Lamba 1, 2017 Mary Ann Liebert, Inc. DOI: 10.1089 / Your.2017.0283